The effect of liver-specific ketohexokinase deletion on the intestinal-liver-kidney axis in high-fructose-induced metabolic syndrome mice
Acta Biochimica et Biophysica Sinica · 2026
DOI: 10.3724/abbs.2025191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2026. Verfasst von Huiru Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Centre, Jiangxi University of Chinese Medicine, Nanchang 330004, China. Hauptthemen laut MEDLINE: Fructokinases, Metabolic Syndrome, Fructose, Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The liver is a crucial site for fructose uptake and metabolism, a function intricately linked to fructose-associated pathologies. This study examines the role of hepatic ketohexokinase (KHK) in metabolic syndrome induced solely by high-fructose intake. Liver-specific Khk-deficient mice are generated and fed with a 20% fructose solution for 3 months, after which the features of metabolic syndrome are examined. Compared with fructose-fed floxed controls, fructose-fed liver-specific Khk-deficient mice present alleviated liver injury and hepatic steatosis, along with lower triglyceride levels in the plasma and liver, plasma aspartate transaminase and alanine transaminase levels, and mRNA levels of genes related to triglyceride and fatty acid synthesis. Liver-specific Khk deficiency also leads to lower uric acid levels in the plasma and urine, as well as xanthine oxidase activity and Glut9 mRNA levels in the liver and kidneys of fructose-fed mice. Although intestinal villus length and epithelial barrier integrity remain unaffected, the deletion of liver Khk significantly reduces fructose-stimulated KHK, Glut2, Glut5, and aldolase B expression in the intestine and kidneys, suggesting inhibited fructose absorption and metabolism in these tissues. In the adipose tissue, fructose-induced increases in adipocyte size and tumor necrosis factor-α and interleukin-6 mRNA levels are blocked by liver-specific Khk deficiency, indicating improved remodeling of adipose tissue and reduced inflammation in adipocytes. Overall, liver-specific Khk deletion is sufficient to protect against metabolic syndrome induced by excessive fructose intake. Our findings underscore the critical role of liver KHK-mediated fructose metabolism in driving the physiological and pathological consequences associated with fructose consumption along the intestinal-liver-kidney axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Medicine Centre, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
- Center for Metabolic Disease Research and Department of Cardiovascular Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Zitieren
APA
Yang, H., Yi, X., Song, S., Wang, M., Tan, W., Zhu, Y., Yu, J., & Xu, C. (2026). The effect of liver-specific ketohexokinase deletion on the intestinal-liver-kidney axis in high-fructose-induced metabolic syndrome mice. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025191
Vancouver
Yang H, Yi X, Song S, Wang M, Tan W, Zhu Y, et al. The effect of liver-specific ketohexokinase deletion on the intestinal-liver-kidney axis in high-fructose-induced metabolic syndrome mice. Acta Biochimica et Biophysica Sinica. 2026. doi:10.3724/abbs.2025191
BibTeX
@article{Yang2026,
author = {Yang, Huiru and Yi, Xiaoli and Song, Shanshan and Wang, Mulan and Tan, Wenting and Zhu, Ying and Yu, Jun and Xu, Chuanming},
title = {The effect of liver-specific ketohexokinase deletion on the intestinal-liver-kidney axis in high-fructose-induced metabolic syndrome mice},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2026},
doi = {10.3724/abbs.2025191}
}
EUVIMED